Clinical Trial: A single-arm, prospective study of lenapalene maintenance therapy in epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, prospective study of lenapalene maintenance therapy in epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136302

Registration Time: 2026/11/09

Type: Observational study

Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349999

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: A single-arm, prospective study of lenapalene maintenance therapy in epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (China)